University of Pittsburgh-製薬・医療分野:企業M&A・提携分析

GlobalDataが発行した調査報告書(DATA8014246)
◆英語タイトル:University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8014246
◆発行会社(リサーチ会社):GlobalData
◆発行日:2017年11月22日
◆ページ数:72
◆レポート形式:英語 / PDF
◆納品方法:Eメール
◆調査対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。GlobalData社の概要及び新刊レポートはこちらでご確認いただけます。

【レポートの概要】

Summary
University of Pittsburgh (Pitt) is an educational research institute that offers undergraduate, graduate and professional programs. The institute provides academic courses in different fields such as business, information sciences, health and rehabilitation, information sciences, engineering, environmental and occupational health, epidemiology, nursing, bioinformatics, biological sciences, pharmacy, arts, social sciences, law, medicine, public and international affairs. It conducts research in the areas such as aging, bioengineering, computer modeling, drug discovery, global health, humanities, international studies, and others. Pitt collaborates with universities for its research activities. The institute is member of the Association of American Universities. Pitt is headquartered in Pittsburgh, Pennsylvania, the US.

University of Pittsburgh – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 9
University of Pittsburgh, Medical Devices Deals, 2011 to YTD 2017 10
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
University of Pittsburgh, Pharmaceuticals & Healthcare, Deal Details 13
Venture Financing 13
Evolent Health Raises US$101.3 Million In Series B Financing 13
Partnerships 15
Aires Pharma Enters into Agreement with University of Pittsburgh 15
University of Pittsburgh and Bayer Form Research Collaboration Agreement 16
University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 17
American Gene Technologies Partners with University of Pittsburgh 18
NanoViricides Enters into Research Agreement with University of Pittsburgh 19
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 20
CareCore National Enters Into Joint Venture Agreement With UPMC 21
Merger 22
Jameson Health System to Merge with UPMC 22
Licensing Agreements 23
Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23
XW Labs Enters into Licensing Agreement with University of Pittsburgh 24
BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 25
Oxis Biotech Enters into Licensing Agreement with University of Pittsburgh 26
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 27
NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 28
Asana Medical Enters into Licensing Agreement with University of Pittsburgh 29
Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 30
DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31
iBio Enters into Licensing Agreement with University of Pittsburgh 32
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 34
Horizon Discovery Enters Into Licensing Agreement With University Of Pittsburgh 35
Stemline Therapeutics Enters Into Licensing Agreement With University Of Pittsburgh 36
Equity Offering 37
Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37
Acquisition 39
University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39
MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40
University of Pittsburgh – Key Competitors 41
University of Pittsburgh – Key Employees 42
University of Pittsburgh – Locations And Subsidiaries 43
Head Office 43
Other Locations & Subsidiaries 43
Recent Developments 46
Government and Public Interest 46
Nov 15, 2017: Wider sampling of tumor tissues may guide drug choice, improve outcomes 46
Nov 14, 2017: Shining a light on the nervous system to thwart disease 48
Oct 31, 2017: NIH establishes new research in social epigenomics to address health disparities 49
May 09, 2017: Precision medicine improves treatment outcomes for some pancreatic cancer patients 52
Dec 07, 2016: NIH/SBIR grant for Liver-on-a-Chip 53
Oct 26, 2016: Study Questions Benefits of Long-Term Home Oxygen Therapy for COPD Patients with Moderately Low Blood Oxygen Levels 54
Oct 07, 2016: University of Pittsburgh Brain Institute Receives Grant from Hillman Foundation to Advance Brain Research 56
Sep 22, 2016: University of Pittsburgh Awarded $14 Million Grant to Study Preconception Effects of Stress on Neurodevelopment 58
Aug 31, 2016: Pitt Researcher Receives Decade of Funding from NIH 59
Aug 22, 2016: New Understanding of Pulmonary Hypertension Leads to Promising Drug Targets 60
Aug 02, 2016: ‘Starving’ Immune Cell Discovery Points to Cancer Immunotherapy-Boosting Strategies 61
Jul 29, 2016: Pitt Researchers Develop a Small-Molecule Switch to Activate Proteins 62
Jul 19, 2016: Childhood Cancer Hijacks Cellular Quality Control System to Fuel Growth 63
Jul 13, 2016: University of Pittsburgh Researchers Part of “BELIEVE” Team that Received $28 Million, Five-Year NIH Award to Find HIV/AIDS Cure 65
Jun 08, 2016: Pitt researchers find key to Parkinson’s disease neurodegeneration 66
Apr 27, 2016: Pitt computational model finds new protein-protein interactions in schizophrenia 67
Mar 21, 2016: Magee-Womens Research Institute Awarded $3.7 Million to Study Pregnancy and Heart Disease 68
Product News 69
May 09, 2016: Pitt-Developed Drug Works Against ‘Superbug’ Biofilms and Respiratory Virus 69
Mar 30, 2016: Pitt Team Redesigns Epilepsy Drug to Increase Potency and Specificity, Reduce Side Effects 71
Appendix 72
Methodology 72
About GlobalData 72
Contact Us 72
Disclaimer 72

List of Tables
University of Pittsburgh, Pharmaceuticals & Healthcare, Key Facts 2
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 6
University of Pittsburgh, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 7
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 8
University of Pittsburgh, Deals By Therapy Area, 2011 to YTD 2017 9
University of Pittsburgh, Medical Devices Deals, 2011 to YTD 2017 10
University of Pittsburgh, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 11
Evolent Health Raises US$101.3 Million In Series B Financing 13
Aires Pharma Enters into Agreement with University of Pittsburgh 15
University of Pittsburgh and Bayer Form Research Collaboration Agreement 16
University of Pittsburgh Cancer Institute Enters into Contract with National Cancer Institute 17
American Gene Technologies Partners with University of Pittsburgh 18
NanoViricides Enters into Research Agreement with University of Pittsburgh 19
GeoVax Labs Enters into Research Agreement with University of Pittsburgh 20
CareCore National Enters Into Joint Venture Agreement With UPMC 21
Jameson Health System to Merge with UPMC 22
Inmune Bio Enters into Licensing Agreement with University of Pittsburgh 23
XW Labs Enters into Licensing Agreement with University of Pittsburgh 24
BioTime Enters into Licensing Agreement with University of Pittsburgh Medical Center 25
Oxis Biotech Enters into Licensing Agreement with University of Pittsburgh 26
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For SL-701 27
NuvOx Pharma Enters into Licensing Agreement with University of Pittsburgh 28
Asana Medical Enters into Licensing Agreement with University of Pittsburgh 29
Oxis Biotech Amends Option Agreement with University of Pittsburgh to License Certain Patents 30
DiaVacs Enters into Licensing Agreement with University Of Pittsburgh 31
iBio Enters into Licensing Agreement with University of Pittsburgh 32
Stemline Therapeutics Enters Into Licensing Agreement With University of Pittsburgh For EphA2 33
ImmunoCellular Enters Into Licensing Agreement With University of Pittsburgh 34
Horizon Discovery Enters Into Licensing Agreement With University Of Pittsburgh 35
Stemline Therapeutics Enters Into Licensing Agreement With University Of Pittsburgh 36
Evolent Health Prices Secondary Offering of Class A Shares for USD159.4 Million 37
University of Pittsburgh Medical Acquires Family Hospice and Palliative Care 39
MedCare Equipment Acquires Great Lakes Home Healthcare Services From UPMC Hamot 40
University of Pittsburgh, Key Competitors 41
University of Pittsburgh, Key Employees 42
University of Pittsburgh, Other Locations 43
University of Pittsburgh, Subsidiaries 43

【免責事項】
http://www.globalresearch.jp/disclaimer

★リサーチレポート[ University of Pittsburgh-製薬・医療分野:企業M&A・提携分析(University of Pittsburgh - Pharmaceuticals & Healthcare - Deals and Alliances Profile)]についてメールでお問い合わせはこちらでお願いします。

◆H&Iグローバルリサーチのお客様(例)◆